Richard Pratley MD (@RpratleyMD) profile picture

Richard Pratley MD

@RpratleyMD

Samuel E Crockett Chair in Diabetes Research, Director, AdventHealth Diabetes Institute, Diabetes Program Director at Translational Research Institute

 Orlando, FL
tri-md.org
Joined October 2014
  • Tweets487
  • Following740
  • Followers684
36Media
Photo by Richard Pratley MD (@RpratleyMD)Photo by Richard Pratley MD (@RpratleyMD)Photo by Richard Pratley MD (@RpratleyMD)Photo by Richard Pratley MD (@RpratleyMD)Photo by Richard Pratley MD (@RpratleyMD)Photo by Richard Pratley MD (@RpratleyMD)Photo by Richard Pratley MD (@RpratleyMD)Photo by Richard Pratley MD (@RpratleyMD)Photo by Richard Pratley MD (@RpratleyMD)Photo by Richard Pratley MD (@RpratleyMD)
Quitting X. No room in my life for toxicity.
2
6
350
Richard Pratley MD retweeted
Daniel J Drucker (@DanielJDrucker) profile picture
Daniel J Drucker@DanielJDrucker28 Jan 2025
The FLOW trial was stopped early due to clear benefits for using semaglutide to reduce progression of kidney disease and cardiovascular death in people with #T2D at risk for progressive diabetic kidney disease @US_FDA @novonordiskus
Image from Daniel J Drucker (@DanielJDrucker)
2
48
2
149
13,954
Richard Pratley MD retweeted
Daniel J Drucker (@DanielJDrucker) profile picture
Daniel J Drucker@DanielJDrucker8 Dec 2024
A special happy birthday to Professor Michael Nauck, a leader in the translational biology of gut hormones and related metabolic therapies #diabetes #Obesity @EASDnews @DiabResearch
Image from Daniel J Drucker (@DanielJDrucker)
2
25
2,016
Richard Pratley MD retweeted
Cristina Popa 🦋 (@NephroSeeker) profile picture
Cristina Popa 🦋@NephroSeeker26 Oct 2024
More on FLOW trial and CV outcomes #kidneywk 🎤Presented by Richard E. Pratley @RpratleyMD Semaglutide reduced the risk of all-cause death and CV death
Image from Cristina Popa 🦋 (@NephroSeeker)
1
1
5
403
Richard Pratley MD retweeted
Gunnar Henrik Heine (@gunnar_heine) profile picture
Gunnar Henrik Heine@gunnar_heine19 Oct 2024
overFLOWing evidence for semaglutide in CKD: here come the heart failure data 😎 Thank you @RpratleyMD @KatherineTuttl8 @P_Rossing @VladoPerkovic and the other FLOW investigators! sciencedirect.com/science/ar…
Image from Gunnar Henrik Heine (@gunnar_heine)
13
45
3,111
Effects of Semaglutide on Heart Failure Outcomes in Diabetes and Chron... sciencedirect.com/science/ar… Just presented at #ESC and published in #JACC - semaglutide decreased risk of heart failure and CV death by 27% in the FLOW trial in T2D and CVD.
1
6
273
Excited to be presenting the results of the FLOW trial - first dedicated CKD trial with a GLP-1 receptor agonist - at the ERA in Stockholm.
Image from Richard Pratley MD (@RpratleyMD)
2
3
3
34
3,121
Join us for a webinar on May 7, 4:00 p.m. ET: "Beyond Basics: Unraveling Challenging Type 2 Diabetes Cases." Learn advanced treatment therapies and decision-making from experts. Register now: bit.ly/4bcyFTh
Image from American Diabetes Association - DiabetesPro (@ADA_DiabetesPro)
3
4
1,018
Support my JDRF One Walk www2.jdrf.org/site/TR?fr_id=…
Join Breakthrough T1D Walk and help create a world without type 1 diabetes (T1D).

Join Breakthrough T1D Walk and help create a world without type 1 diabetes (T1D).

The Breakthrough T1D Walk is a community celebration for those living with T1D and the research advancements we've all worked together to achieve. It's where dedicated families, friends and companies...

breakthrought1d.org
1
136
Richard Pratley MD retweeted
Cell Metabolism (@Cell_Metabolism) profile picture
Cell Metabolism@Cell_Metabolism2 Apr 2024
Proudly presenting Part II of our #SpecialIssue on Preventing Metabolic Disease! “Variability is the law of life, and as no two faces are the same, so no two bodies are alike.”—Sir William Osler, 1903. Covert Art: Julia Saxton Noone and Mucinski et al. discuss individual response to exercise which must be synergistically considered for effective personalized preventative medicine. 🔗Article: cell.com/cell-metabolism/abs… 🔗Special Issue: cell.com/issue/S1550-4131(23… @AdventHealthCFL #BretGoodpaster #LaurenSparks
Image from Cell Metabolism (@Cell_Metabolism)
15
4
41
20,471
Richard Pratley MD retweeted
Endocrine Today (@EndocrineToday) profile picture
Endocrine Today@EndocrineToday23 Jan 2024
📰Pancreatic #diabetes may be nearly as common as type 1 diabetes, but much less is known about the condition. Learn more about pancreatic diabetes in this Healio Exclusive from @EndocrineToday: 👇 @RPratleyMD healio.com/news/endocrinolog…
NIH programs aim to shed light on, optimize care for pancreatic diabetes

NIH programs aim to shed light on, optimize care for pancreatic diabetes

Pancreatic diabetes may be as prevalent as type 1 diabetes, but knowledge of the disease is lacking. Several research programs are working to change that.The confusion with pancreatic diabetes begins...

healio.com
1
4
335
Richard Pratley MD retweeted
Daniel J Drucker (@DanielJDrucker) profile picture
Daniel J Drucker@DanielJDrucker20 Dec 2023
Real world data in millions of PPL with metabolic liver disease and #T2D reveals GLP-1RAs are associated with lower incidences of adverse CVEs and all-cause mortality #CVD #heartdisase @DiabetologiaJnl link.springer.com/article/10…
Image from Daniel J Drucker (@DanielJDrucker)
15
38
4,233
Richard Pratley MD retweeted
Hilly Paige Jr (@hillypaige2) profile picture
Hilly Paige Jr@hillypaige29 Dec 2023
#WCIRDC23 👏👏👏 to @YHandelsmanMD & the program committee for another superb @WCIRDC! Full house every day! 🙏🏻 to all of the supporting companies! @Amgen @BayerPharma @AstraZenecaUS @boehringerus @EliLillyandCo @LexPharma @EsperionInc @GoHealio @MIOAmerica @HeartinDiabetes
Image from Hilly Paige Jr (@hillypaige2)
Image from Hilly Paige Jr (@hillypaige2)
Image from Hilly Paige Jr (@hillypaige2)
4
12
366
Richard Pratley MD retweeted
CME Outfitters (@cmeoutfitters) profile picture
CME Outfitters
@cmeoutfitters3 Dec 2023
Wrapping up Day of of Clinical Pathways in #T2D Care: Overcoming Inertia, Implementing Innovation Dr. Tim Garvey, @RpratleyMD, @RothbergAmy and Michele Tedder
Image from CME Outfitters (@cmeoutfitters)
Image from CME Outfitters (@cmeoutfitters)
Image from CME Outfitters (@cmeoutfitters)
Image from CME Outfitters (@cmeoutfitters)
2
10
223
Richard Pratley MD retweeted
Daniel J Drucker (@DanielJDrucker) profile picture
Daniel J Drucker@DanielJDrucker2 Nov 2023
In the dynamic ebb and flow of the GLP-1 space beyond #T2D #obesity does @EliLillyandCo have the edge in portfolio depth, whereas @novonordisk leads in the breadth of expanding the evidence base for semaglutide? Discuss
Image from Daniel J Drucker (@DanielJDrucker)
1
10
46
8,752
Richard Pratley MD retweeted
Vlado Perkovic (@VladoPerkovic) profile picture
Vlado Perkovic@VladoPerkovic10 Oct 2023
Big news: the FLOW trial of semaglutide for kidney protection in CKD stopped at pre-planned interim analysis. Trial now to close out and results will be available in first half of 2024. #FLOWtrial #semaglutide #ozempic
Image from Vlado Perkovic (@VladoPerkovic)
6
61
9
163
33,469
Exciting news for #DKD. Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on interim analysis globenewswire.com/news-relea…
Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on...

Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on...

Novo Nordisk will stop the once-weekly injectable semaglutide kidney outcomes trial, FLOW, based on interim analysis Bagsværd, Denmark, 10 October 2023 –...

globenewswire.com
1
1
11
407
Can’t tell if Penny is excited about the new mobile groomer or just happy she has had lots of treats #GoldenPenny
Image from Richard Pratley MD (@RpratleyMD)
2
4
235
Harpreet Bajaj reviewing #diabetes #remission @ #diabetesdialog2023 hosted by the Barbara Davis Center for Diabetes - a new pathway for early #T2D
Image from Richard Pratley MD (@RpratleyMD)
2
8
547
Load more